Anthony Mills, MD

Men's Health

Disclosure(s): Gilead Sciences: Advisor/Consultant, Grant/Research Support; Merck: Advisor/Consultant, Grant/Research Support; ViiV: Advisor/Consultant, Grant/Research Support

Poster(s):

• 2087 - Prescription Adherence and Persistence on Oral Pre-exposure Prophylaxis (PrEP) Among PrEP-Naive (PN) Individuals After F/TAF Approval in the United States (US)
  Saturday, October 22, 2022

  12:15 PM – 1:30 PM US ET